The World’s Health Care Crisis

From the Laboratory Bench to the Patient’s Bedside

At present, human society is facing a health care crisis that is affecting patients worldwide. In the United States, it is generally believed that the major problem is lack of affordable access to health care (i.e. health insurance). This book takes an unprecedented approach to address this issue by proposing that the major problem is not lack of affordable access to health care per se, but lack of access to better, safer, and more affordable medicines. The latter problem is present not only in the United States and the developing world but also in countries with socialized health care systems, such as Europe and the rest of the industrialized world. This book provides a comparative analysis of the health care systems throughout the world and also examines the biotechnology and pharmaceutical industries.
View full description

Audience

The pharmaceutical industry, investment banks with an interest in healthcare, healthcare investors, management consultancies with healthcare practices, economists with an interest in healthcare, reimbursement agencies, regulatory bodies (e.g. the FDA and EMEA), government, politicians and policy makers.

 

Book information

  • Published: July 2011
  • Imprint: ELSEVIER
  • ISBN: 978-0-12-391875-8

Reviews

"This book is an excellent summary of the health-care crisis facing the world today, comparing health care in wealthy, industrial countries to that in poor, underdeveloped countries. Sánchez-Serrano, a Panamian health-care adviser/consultant, covers the history of health care, including pharmaceutically driven treatments; challenges with new drug discoveries; unmet medical needs; and profits. The author also emphasizes the high cost of research and development for new drugs. He explores the issues related to government-supplemented research and summarizes the interaction of government-sponsored basic research, academic (pure) science research, venture capital investors, and industry…. The author provides many specific examples of successes and failures of past/present systems and discusses the evolution of pharmaceutical company philosophies in the past 150 years and future challenges. This book is fact based and nonpartisan. The only areas not explored are the modern diagnostics industry, the phenomenal advances in medical devices, and the cost of modern physician care (and the cost of physicians' education). Summing Up: Highly Recommended"--CHOICE




Table of Contents

PART I: THE GLOBAL HEALTH CARE CRISIS

1. The World’s Health Care Crisis: The United States’ Leadership

2. The Health Care Crisis in Other Parts of the World

PART II: UNDERSTANDING THE BIOPHARMACEUTICAL BUSINESS

3. Brief Commercial History of the Biopharmaceutical Industry up to the Year 2000

4. The Biopharmaceutical Industry in the Twenty-first Century: Titanic Challenges Ahead

5. Understanding Research and Development and Marketing in a Biopharmaceutical Company

6. The Pharmaceutical Regulators

PART III: THE COMPLEXITY OF INNOVATION

7. The Academia-Industry Relationship

8. Translating Academic Innovation into Health Care Products

9. The Biotechnology World and Its Challenges

10. Causes of the Pharmaceutical Crisis

PART IV: MORALITY AND DUTY ON A LONELY PLANET

11. Wealth versus Poverty

12. Social Responsibility, Governmental Role, and Nongovernmental Organizations

PART V: REINVENTING RESEARCH AND DEVELOPMENT

13. Time for Reorganization